OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ASTRAZENECA PLC DL-,25/  GB0009895292  /

Lang & Schwarz
2024-05-13  11:00:17 PM Chg. -0.100 Volume Bid11:00:17 PM Ask11:00:17 PM Market Capitalization Dividend Y. P/E Ratio
142.650EUR -0.07% -
Turnover: -		 142.650Bid Size: - 143.550Ask Size: - 222.56 bill.EUR - -
GlobeNewswire 05-13 Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-13 Kuehn Law Encourages AGS, FUSN, CVLY, and DRQ Investors to Contact Law Firm
GlobeNewswire 05-13 Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-13 Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
GlobeNewswire 05-13 Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire 05-08 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 05-06 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 05-06 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 02-22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 02-22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 02-20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 02-09 Europe mostly lower premarket amid German CPI, earnings
TeleTrader 02-08 Europe closes mostly higher following earnings